Skip to content

Angiotensin Receptor Blockers in Aortic Stenosis

Aortic Stenosis | Aortic Valve Stenosis

This study is intended to investigate the effect of angiotensin receptor blockers (ARBs) on mild-to-moderate aortic stenosis.

null

Participation Requirements

  • Sex:

    ALL
  • Eligible Ages:

    20 and up

Participation Criteria

Inclusion Criteria:

* Mild to moderate aortic stenosis (peak aortic jet velocity ≥2.5 and \<4m/s)
* Normal left ventricular ejection fraction (i.e. ≥50%)
* Systolic blood pressure \>110 mmHg
* Diastolic blood pressure \>70 mmHg

Exclusion Criteria:

* More than mild aortic or mitral regurgitation, or mitral stenosis
* Current use or documented indication for renin-angiotensin system medication or Aliskiren
* Known allergy or intolerance to angiotensin II receptor blockers (ARBs)
* Alzheimer, dementia or known non-compliant patient
* Renal dysfunction (glomerular filtration rate \<30ml/min/1.73m2)
* Chronic hyperkalemia
* Diagnosed hepatic failure, cirrhosis, hepatitis or history of hepatic impairment
* Newly diagnosed (\<2 months) or poorly controlled diabetes
* Pre-existing obstructive coronary artery disease with CCS III-IV angina or recent myocardial infarction (\<3 months)
* Pregnant or lactating women
* Patients unable to read, understand or sign research consent

Study Location

CRIUCPQ
CRIUCPQ
Québec, Quebec
Canada

Contact Study Team

Primary Contact

Marie-Annick Clavel, PhD

[email protected]
418-656-8711
Backup Contact

Marie-Annick Clavel

Study Sponsored By
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Participants Required
More Information
Study ID: NCT04913870